Open access · CC-BY
via OpenAlex
Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms
Kristina Endres, Thomas Deller
Frontiers in Molecular Neuroscience · 2017 · ▲ 95 citations
Abstract
ADAM10 (A Disintegrin and Metalloproteinase 10) has been identified as the major physiological alpha-secretase in neurons, responsible for cleaving APP in a non-amyloidogenic manner. This cleavage results in the production of a neuroprotective APP-derived fragment, APPs-alpha, and an attenuated production of neurotoxic A-beta peptides. An increase in ADAM10 activity shifts the balance of APP processing towards APPs-alpha and protects the brain from amyloid deposition and disease. Thus, increasing ADAM10 activity has been proposed an attractive target for the treatment of neurodegenerative diseases and it appears to be timely to investigate the physiological mechanisms regulating ADAM10 expression. Therefore in this article, we will (1) review reports on the physiological regulation of ADAM10 at the transcriptional level, by epigenetic factors, miRNAs and/or protein interactions, (2) describe conditions, which change ADAM10 expression in vitro and in vivo, (3) report how neuronal ADAM10 expression may be regulated in humans, and (4) discuss how this knowledge on the physiological and pathophysiological regulation of ADAM10 may help to preserve or restore brain function.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fnmol.2017.00056
- Canonical
- link ↗
- Fetched
- 2026-07-25 MST
Cite this
APA
Endres, K., & Deller, T. (2017). Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms. <em>Frontiers in Molecular Neuroscience</em>. https://doi.org/10.3389/fnmol.2017.00056
Vancouver
Endres K, Deller T. Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms. Frontiers in Molecular Neuroscience. 2017. doi:10.3389/fnmol.2017.00056.
BibTeX
@article{kristina2017Regula,
title = {Regulation of Alpha-Secretase ADAM10 In vitro and In vivo: Genetic, Epigenetic, and Protein-Based Mechanisms},
author = {Kristina Endres and Thomas Deller},
journal = {Frontiers in Molecular Neuroscience},
year = {2017},
doi = {10.3389/fnmol.2017.00056},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2024
Open access · CC-BY
An Overview of the Epigenetic Modifications in the Brain under Normal and Pathological Conditions
Trends in Neurosciences 2018
Citation only
Epigenetic Regulation in Neurodegenerative Diseases
Frontiers in Behavioral Neuroscience 2015
Open access · CC-BY
Epigenetic Alterations in Alzheimer’s Disease
International journal of molecular sciences 2026
Open access · OA
Epigenetic Mechanisms in Neurodegenerative Diseases: From Genetic Regulation to Therapeutic Potential
Ageing research reviews 2026
Citation only
The nutrition-sleep-circadian axis in age-related neurodegeneration: Cellular mechanisms, metabolic dysfunction, and neuroprotective interventions.
Nutrients 2026
Open access · OA